nodes	percent_of_prediction	percent_of_DWPC	metapath
Trihexyphenidyl—Cognitive impairment—Betamethasone—multiple sclerosis	0.0254	0.0335	CcSEcCtD
Trihexyphenidyl—Cognitive impairment—Dexamethasone—multiple sclerosis	0.0254	0.0335	CcSEcCtD
Trihexyphenidyl—Cognitive impairment—Prednisone—multiple sclerosis	0.0221	0.0292	CcSEcCtD
Trihexyphenidyl—Sinus bradycardia—Mitoxantrone—multiple sclerosis	0.0197	0.0261	CcSEcCtD
Trihexyphenidyl—Cognitive impairment—Methotrexate—multiple sclerosis	0.0185	0.0244	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Prednisolone—multiple sclerosis	0.0181	0.0238	CcSEcCtD
Trihexyphenidyl—Cognitive disorder—Methylprednisolone—multiple sclerosis	0.0169	0.0222	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Triamcinolone—multiple sclerosis	0.0166	0.0219	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Methylprednisolone—multiple sclerosis	0.0166	0.0219	CcSEcCtD
Trihexyphenidyl—Cognitive disorder—Dexamethasone—multiple sclerosis	0.0153	0.0202	CcSEcCtD
Trihexyphenidyl—Cognitive disorder—Betamethasone—multiple sclerosis	0.0153	0.0202	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Betamethasone—multiple sclerosis	0.0151	0.0199	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Dexamethasone—multiple sclerosis	0.0151	0.0199	CcSEcCtD
Trihexyphenidyl—Weight decreased—Fingolimod—multiple sclerosis	0.0148	0.0195	CcSEcCtD
Trihexyphenidyl—Cognitive disorder—Prednisone—multiple sclerosis	0.0133	0.0176	CcSEcCtD
Trihexyphenidyl—Blindness—Triamcinolone—multiple sclerosis	0.0132	0.0174	CcSEcCtD
Trihexyphenidyl—Blindness—Methylprednisolone—multiple sclerosis	0.0132	0.0174	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Prednisone—multiple sclerosis	0.0131	0.0173	CcSEcCtD
Trihexyphenidyl—Blindness—Betamethasone—multiple sclerosis	0.012	0.0158	CcSEcCtD
Trihexyphenidyl—Blindness—Dexamethasone—multiple sclerosis	0.012	0.0158	CcSEcCtD
Trihexyphenidyl—Cognitive disorder—Methotrexate—multiple sclerosis	0.0112	0.0147	CcSEcCtD
Trihexyphenidyl—Vision blurred—Fingolimod—multiple sclerosis	0.0107	0.0141	CcSEcCtD
Trihexyphenidyl—Delusion—Methylprednisolone—multiple sclerosis	0.0103	0.0136	CcSEcCtD
Trihexyphenidyl—Mydriasis—Prednisolone—multiple sclerosis	0.00996	0.0131	CcSEcCtD
Trihexyphenidyl—Delusion—Dexamethasone—multiple sclerosis	0.00937	0.0124	CcSEcCtD
Trihexyphenidyl—Delusion—Betamethasone—multiple sclerosis	0.00937	0.0124	CcSEcCtD
Trihexyphenidyl—Delusion—Prednisone—multiple sclerosis	0.00816	0.0108	CcSEcCtD
Trihexyphenidyl—Memory impairment—Prednisone—multiple sclerosis	0.00736	0.0097	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Prednisolone—multiple sclerosis	0.00683	0.00901	CcSEcCtD
Trihexyphenidyl—Asthenia—Fingolimod—multiple sclerosis	0.00665	0.00878	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Triamcinolone—multiple sclerosis	0.00628	0.00828	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Methylprednisolone—multiple sclerosis	0.00626	0.00826	CcSEcCtD
Trihexyphenidyl—Dizziness—Fingolimod—multiple sclerosis	0.00613	0.00809	CcSEcCtD
Trihexyphenidyl—Headache—Fingolimod—multiple sclerosis	0.00581	0.00766	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Dexamethasone—multiple sclerosis	0.0057	0.00751	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Betamethasone—multiple sclerosis	0.0057	0.00751	CcSEcCtD
Trihexyphenidyl—Weight decreased—Mitoxantrone—multiple sclerosis	0.0055	0.00725	CcSEcCtD
Trihexyphenidyl—Drowsiness—Mitoxantrone—multiple sclerosis	0.00542	0.00715	CcSEcCtD
Trihexyphenidyl—Confusional state—Cladribine—multiple sclerosis	0.0053	0.00699	CcSEcCtD
Trihexyphenidyl—Dry skin—Prednisolone—multiple sclerosis	0.00529	0.00697	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Methylprednisolone—multiple sclerosis	0.00517	0.00682	CcSEcCtD
Trihexyphenidyl—Tachycardia—Cladribine—multiple sclerosis	0.00513	0.00677	CcSEcCtD
Trihexyphenidyl—Hyperkinesia—Prednisone—multiple sclerosis	0.00504	0.00664	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Prednisone—multiple sclerosis	0.00496	0.00654	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Dexamethasone—multiple sclerosis	0.0047	0.0062	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Betamethasone—multiple sclerosis	0.0047	0.0062	CcSEcCtD
Trihexyphenidyl—Somnolence—Cladribine—multiple sclerosis	0.00467	0.00617	CcSEcCtD
Trihexyphenidyl—Constipation—Cladribine—multiple sclerosis	0.0045	0.00593	CcSEcCtD
Trihexyphenidyl—Dry skin—Betamethasone—multiple sclerosis	0.00441	0.00582	CcSEcCtD
Trihexyphenidyl—Dry skin—Dexamethasone—multiple sclerosis	0.00441	0.00582	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Cladribine—multiple sclerosis	0.00433	0.00571	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Prednisone—multiple sclerosis	0.00409	0.0054	CcSEcCtD
Trihexyphenidyl—Vision blurred—Mitoxantrone—multiple sclerosis	0.00399	0.00526	CcSEcCtD
Trihexyphenidyl—Dry skin—Prednisone—multiple sclerosis	0.00384	0.00507	CcSEcCtD
Trihexyphenidyl—Asthenia—Cladribine—multiple sclerosis	0.00377	0.00498	CcSEcCtD
Trihexyphenidyl—Weight decreased—Dexamethasone—multiple sclerosis	0.00376	0.00496	CcSEcCtD
Trihexyphenidyl—Weight decreased—Betamethasone—multiple sclerosis	0.00376	0.00496	CcSEcCtD
Trihexyphenidyl—Hallucination—Methylprednisolone—multiple sclerosis	0.00364	0.00481	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Azathioprine—multiple sclerosis	0.00352	0.00465	CcSEcCtD
Trihexyphenidyl—Confusional state—Mitoxantrone—multiple sclerosis	0.00348	0.0046	CcSEcCtD
Trihexyphenidyl—Dizziness—Cladribine—multiple sclerosis	0.00348	0.00459	CcSEcCtD
Trihexyphenidyl—Tachycardia—Mitoxantrone—multiple sclerosis	0.00337	0.00445	CcSEcCtD
Trihexyphenidyl—Vomiting—Cladribine—multiple sclerosis	0.00334	0.00441	CcSEcCtD
Trihexyphenidyl—Rash—Cladribine—multiple sclerosis	0.00331	0.00437	CcSEcCtD
Trihexyphenidyl—Hallucination—Betamethasone—multiple sclerosis	0.00331	0.00437	CcSEcCtD
Trihexyphenidyl—Hallucination—Dexamethasone—multiple sclerosis	0.00331	0.00437	CcSEcCtD
Trihexyphenidyl—Dermatitis—Cladribine—multiple sclerosis	0.00331	0.00437	CcSEcCtD
Trihexyphenidyl—Headache—Cladribine—multiple sclerosis	0.00329	0.00434	CcSEcCtD
Trihexyphenidyl—Weight decreased—Prednisone—multiple sclerosis	0.00328	0.00432	CcSEcCtD
Trihexyphenidyl—Vision blurred—Prednisolone—multiple sclerosis	0.00327	0.00432	CcSEcCtD
Trihexyphenidyl—Nausea—Cladribine—multiple sclerosis	0.00312	0.00412	CcSEcCtD
Trihexyphenidyl—Somnolence—Mitoxantrone—multiple sclerosis	0.00307	0.00405	CcSEcCtD
Trihexyphenidyl—Constipation—Mitoxantrone—multiple sclerosis	0.00295	0.0039	CcSEcCtD
Trihexyphenidyl—Hallucination—Prednisone—multiple sclerosis	0.00288	0.00381	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00285	0.00376	CcSEcCtD
Trihexyphenidyl—Dizziness—Azathioprine—multiple sclerosis	0.00283	0.00373	CcSEcCtD
Trihexyphenidyl—Tachycardia—Prednisolone—multiple sclerosis	0.00277	0.00365	CcSEcCtD
Trihexyphenidyl—Vomiting—Azathioprine—multiple sclerosis	0.00272	0.00359	CcSEcCtD
Trihexyphenidyl—Drowsiness—Methotrexate—multiple sclerosis	0.0027	0.00356	CcSEcCtD
Trihexyphenidyl—Rash—Azathioprine—multiple sclerosis	0.00269	0.00356	CcSEcCtD
Trihexyphenidyl—Dermatitis—Azathioprine—multiple sclerosis	0.00269	0.00355	CcSEcCtD
Trihexyphenidyl—Headache—Azathioprine—multiple sclerosis	0.00268	0.00353	CcSEcCtD
Trihexyphenidyl—Confusional state—Methylprednisolone—multiple sclerosis	0.00262	0.00346	CcSEcCtD
Trihexyphenidyl—Tachycardia—Triamcinolone—multiple sclerosis	0.00254	0.00336	CcSEcCtD
Trihexyphenidyl—Nausea—Azathioprine—multiple sclerosis	0.00254	0.00335	CcSEcCtD
Trihexyphenidyl—Tachycardia—Methylprednisolone—multiple sclerosis	0.00254	0.00335	CcSEcCtD
Trihexyphenidyl—Asthenia—Mitoxantrone—multiple sclerosis	0.00248	0.00327	CcSEcCtD
Trihexyphenidyl—Vision blurred—Prednisone—multiple sclerosis	0.00238	0.00314	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Prednisolone—multiple sclerosis	0.00234	0.00308	CcSEcCtD
Trihexyphenidyl—Agitation—Prednisone—multiple sclerosis	0.00232	0.00306	CcSEcCtD
Trihexyphenidyl—Tachycardia—Dexamethasone—multiple sclerosis	0.00231	0.00305	CcSEcCtD
Trihexyphenidyl—Tachycardia—Betamethasone—multiple sclerosis	0.00231	0.00305	CcSEcCtD
Trihexyphenidyl—Vomiting—Mitoxantrone—multiple sclerosis	0.0022	0.0029	CcSEcCtD
Trihexyphenidyl—Rash—Mitoxantrone—multiple sclerosis	0.00218	0.00287	CcSEcCtD
Trihexyphenidyl—Dermatitis—Mitoxantrone—multiple sclerosis	0.00218	0.00287	CcSEcCtD
Trihexyphenidyl—Headache—Mitoxantrone—multiple sclerosis	0.00216	0.00286	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00215	0.00283	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00214	0.00283	CcSEcCtD
Trihexyphenidyl—Nausea—Mitoxantrone—multiple sclerosis	0.00205	0.00271	CcSEcCtD
Trihexyphenidyl—Tachycardia—Prednisone—multiple sclerosis	0.00201	0.00265	CcSEcCtD
Trihexyphenidyl—Vision blurred—Methotrexate—multiple sclerosis	0.00199	0.00262	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Betamethasone—multiple sclerosis	0.00195	0.00257	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00195	0.00257	CcSEcCtD
Trihexyphenidyl—Dizziness—Prednisolone—multiple sclerosis	0.00187	0.00247	CcSEcCtD
Trihexyphenidyl—Asthenia—Triamcinolone—multiple sclerosis	0.00187	0.00247	CcSEcCtD
Trihexyphenidyl—Asthenia—Methylprednisolone—multiple sclerosis	0.00187	0.00246	CcSEcCtD
Trihexyphenidyl—Rash—Prednisolone—multiple sclerosis	0.00179	0.00236	CcSEcCtD
Trihexyphenidyl—Dermatitis—Prednisolone—multiple sclerosis	0.00179	0.00236	CcSEcCtD
Trihexyphenidyl—Headache—Prednisolone—multiple sclerosis	0.00178	0.00234	CcSEcCtD
Trihexyphenidyl—Constipation—Prednisone—multiple sclerosis	0.00176	0.00232	CcSEcCtD
Trihexyphenidyl—Confusional state—Methotrexate—multiple sclerosis	0.00174	0.00229	CcSEcCtD
Trihexyphenidyl—Dizziness—Triamcinolone—multiple sclerosis	0.00172	0.00227	CcSEcCtD
Trihexyphenidyl—Dizziness—Methylprednisolone—multiple sclerosis	0.00172	0.00227	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Prednisone—multiple sclerosis	0.0017	0.00224	CcSEcCtD
Trihexyphenidyl—Asthenia—Dexamethasone—multiple sclerosis	0.0017	0.00224	CcSEcCtD
Trihexyphenidyl—Asthenia—Betamethasone—multiple sclerosis	0.0017	0.00224	CcSEcCtD
Trihexyphenidyl—Nausea—Prednisolone—multiple sclerosis	0.00168	0.00222	CcSEcCtD
Trihexyphenidyl—Vomiting—Triamcinolone—multiple sclerosis	0.00166	0.00219	CcSEcCtD
Trihexyphenidyl—Vomiting—Methylprednisolone—multiple sclerosis	0.00165	0.00218	CcSEcCtD
Trihexyphenidyl—Rash—Triamcinolone—multiple sclerosis	0.00164	0.00217	CcSEcCtD
Trihexyphenidyl—Dermatitis—Triamcinolone—multiple sclerosis	0.00164	0.00217	CcSEcCtD
Trihexyphenidyl—Rash—Methylprednisolone—multiple sclerosis	0.00164	0.00216	CcSEcCtD
Trihexyphenidyl—Dermatitis—Methylprednisolone—multiple sclerosis	0.00164	0.00216	CcSEcCtD
Trihexyphenidyl—Headache—Triamcinolone—multiple sclerosis	0.00163	0.00215	CcSEcCtD
Trihexyphenidyl—Headache—Methylprednisolone—multiple sclerosis	0.00163	0.00215	CcSEcCtD
Trihexyphenidyl—Dizziness—Betamethasone—multiple sclerosis	0.00156	0.00206	CcSEcCtD
Trihexyphenidyl—Dizziness—Dexamethasone—multiple sclerosis	0.00156	0.00206	CcSEcCtD
Trihexyphenidyl—Nausea—Triamcinolone—multiple sclerosis	0.00155	0.00204	CcSEcCtD
Trihexyphenidyl—Nausea—Methylprednisolone—multiple sclerosis	0.00155	0.00204	CcSEcCtD
Trihexyphenidyl—Somnolence—Methotrexate—multiple sclerosis	0.00153	0.00202	CcSEcCtD
Trihexyphenidyl—Vomiting—Dexamethasone—multiple sclerosis	0.0015	0.00198	CcSEcCtD
Trihexyphenidyl—Vomiting—Betamethasone—multiple sclerosis	0.0015	0.00198	CcSEcCtD
Trihexyphenidyl—Rash—Dexamethasone—multiple sclerosis	0.00149	0.00197	CcSEcCtD
Trihexyphenidyl—Rash—Betamethasone—multiple sclerosis	0.00149	0.00197	CcSEcCtD
Trihexyphenidyl—Dermatitis—Betamethasone—multiple sclerosis	0.00149	0.00197	CcSEcCtD
Trihexyphenidyl—Dermatitis—Dexamethasone—multiple sclerosis	0.00149	0.00197	CcSEcCtD
Trihexyphenidyl—Headache—Betamethasone—multiple sclerosis	0.00148	0.00195	CcSEcCtD
Trihexyphenidyl—Headache—Dexamethasone—multiple sclerosis	0.00148	0.00195	CcSEcCtD
Trihexyphenidyl—Asthenia—Prednisone—multiple sclerosis	0.00148	0.00195	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Methotrexate—multiple sclerosis	0.00142	0.00187	CcSEcCtD
Trihexyphenidyl—Nausea—Betamethasone—multiple sclerosis	0.0014	0.00185	CcSEcCtD
Trihexyphenidyl—Nausea—Dexamethasone—multiple sclerosis	0.0014	0.00185	CcSEcCtD
Trihexyphenidyl—Dizziness—Prednisone—multiple sclerosis	0.00136	0.0018	CcSEcCtD
Trihexyphenidyl—Vomiting—Prednisone—multiple sclerosis	0.00131	0.00173	CcSEcCtD
Trihexyphenidyl—Rash—Prednisone—multiple sclerosis	0.0013	0.00171	CcSEcCtD
Trihexyphenidyl—Dermatitis—Prednisone—multiple sclerosis	0.0013	0.00171	CcSEcCtD
Trihexyphenidyl—Headache—Prednisone—multiple sclerosis	0.00129	0.0017	CcSEcCtD
Trihexyphenidyl—Asthenia—Methotrexate—multiple sclerosis	0.00124	0.00163	CcSEcCtD
Trihexyphenidyl—Nausea—Prednisone—multiple sclerosis	0.00122	0.00161	CcSEcCtD
Trihexyphenidyl—Dizziness—Methotrexate—multiple sclerosis	0.00114	0.0015	CcSEcCtD
Trihexyphenidyl—Vomiting—Methotrexate—multiple sclerosis	0.00109	0.00144	CcSEcCtD
Trihexyphenidyl—Rash—Methotrexate—multiple sclerosis	0.00109	0.00143	CcSEcCtD
Trihexyphenidyl—Dermatitis—Methotrexate—multiple sclerosis	0.00108	0.00143	CcSEcCtD
Trihexyphenidyl—Headache—Methotrexate—multiple sclerosis	0.00108	0.00142	CcSEcCtD
Trihexyphenidyl—Nausea—Methotrexate—multiple sclerosis	0.00102	0.00135	CcSEcCtD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000224	0.000927	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CCL3—multiple sclerosis	0.000222	0.000917	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CCL3—multiple sclerosis	0.000221	0.000915	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000221	0.000914	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—CCR2—multiple sclerosis	0.00022	0.000911	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CCL3—multiple sclerosis	0.000219	0.000906	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—CCR2—multiple sclerosis	0.000218	0.000902	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000216	0.000891	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000214	0.000883	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—PTGER4—multiple sclerosis	0.000213	0.00088	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—CCL5—multiple sclerosis	0.000213	0.00088	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—RGS1—multiple sclerosis	0.000212	0.000877	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—RGS1—multiple sclerosis	0.000212	0.000874	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—CCR5—multiple sclerosis	0.000211	0.000873	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—PTGER4—multiple sclerosis	0.000211	0.000872	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—RGS1—multiple sclerosis	0.00021	0.000866	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000208	0.000861	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000206	0.000853	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CXCR3—multiple sclerosis	0.000206	0.00085	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000204	0.000843	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—CCL5—multiple sclerosis	0.000204	0.000843	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CXCR3—multiple sclerosis	0.000204	0.000842	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—CNR1—multiple sclerosis	0.000203	0.000841	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—CCR5—multiple sclerosis	0.000202	0.000836	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—CNR1—multiple sclerosis	0.000201	0.000832	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—GPR65—multiple sclerosis	0.000201	0.000832	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CCR2—multiple sclerosis	0.000201	0.00083	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—GPR65—multiple sclerosis	0.000201	0.000829	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CCR2—multiple sclerosis	0.0002	0.000827	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000199	0.000824	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—GPR65—multiple sclerosis	0.000199	0.000821	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CCR2—multiple sclerosis	0.000198	0.000819	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000198	0.000817	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—POMC—multiple sclerosis	0.000197	0.000814	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000197	0.000814	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—POMC—multiple sclerosis	0.000196	0.000812	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—POMC—multiple sclerosis	0.000195	0.000804	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CCL3—multiple sclerosis	0.000195	0.000804	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000194	0.000801	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—CCL2—multiple sclerosis	0.000193	0.000797	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—CCL2—multiple sclerosis	0.000192	0.000794	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—CCR5—multiple sclerosis	0.000192	0.000793	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—CCL2—multiple sclerosis	0.00019	0.000786	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—IL2RA—multiple sclerosis	0.000189	0.000781	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PTGER4—multiple sclerosis	0.000187	0.000774	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CCL3—multiple sclerosis	0.000186	0.00077	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CNR1—multiple sclerosis	0.000185	0.000766	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CNR1—multiple sclerosis	0.000185	0.000763	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PGR—multiple sclerosis	0.000184	0.000762	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CXCL13—multiple sclerosis	0.000184	0.000761	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CCR1—multiple sclerosis	0.000184	0.000761	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—CCR5—multiple sclerosis	0.000184	0.000759	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000184	0.000759	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CXCL13—multiple sclerosis	0.000183	0.000758	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CCR1—multiple sclerosis	0.000183	0.000758	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000183	0.000757	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CNR1—multiple sclerosis	0.000183	0.000756	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CCR1—multiple sclerosis	0.000182	0.000751	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CXCL13—multiple sclerosis	0.000182	0.000751	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000181	0.000749	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—IL2RA—multiple sclerosis	0.000181	0.000748	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CXCR3—multiple sclerosis	0.000181	0.000747	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PTGER4—multiple sclerosis	0.000179	0.000741	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CD28—multiple sclerosis	0.000179	0.00074	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PGR—multiple sclerosis	0.000177	0.00073	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CCR2—multiple sclerosis	0.000176	0.000727	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CXCR3—multiple sclerosis	0.000173	0.000716	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CD28—multiple sclerosis	0.000172	0.000709	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CCR2—multiple sclerosis	0.000168	0.000696	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000167	0.000689	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CXCL10—multiple sclerosis	0.000166	0.000687	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—POMC—multiple sclerosis	0.000165	0.000682	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CXCL10—multiple sclerosis	0.000165	0.000681	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CNR1—multiple sclerosis	0.000162	0.000671	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Circadian rythm related genes—IL6—multiple sclerosis	0.00016	0.000662	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—POMC—multiple sclerosis	0.000158	0.000654	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000158	0.000654	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—CCL5—multiple sclerosis	0.000158	0.000651	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—CCL5—multiple sclerosis	0.000156	0.000645	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CNR1—multiple sclerosis	0.000155	0.000642	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000152	0.000627	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000151	0.000625	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—POMC—multiple sclerosis	0.00015	0.00062	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—CCL2—multiple sclerosis	0.000147	0.000606	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CXCL10—multiple sclerosis	0.000146	0.000604	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—POMC—multiple sclerosis	0.000144	0.000593	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CCL5—multiple sclerosis	0.000144	0.000593	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CCL5—multiple sclerosis	0.000143	0.000592	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000142	0.000589	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—CCR5—multiple sclerosis	0.000142	0.000587	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CCL5—multiple sclerosis	0.000142	0.000586	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—CCR5—multiple sclerosis	0.000141	0.000581	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—CCL2—multiple sclerosis	0.000141	0.000581	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.00014	0.00058	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CXCL10—multiple sclerosis	0.00014	0.000578	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—IL2RA—multiple sclerosis	0.00014	0.000578	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000139	0.000573	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—BCHE—multiple sclerosis	0.000138	0.000569	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—TYK2—multiple sclerosis	0.000133	0.000551	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CCL3—multiple sclerosis	0.000131	0.000542	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CCL3—multiple sclerosis	0.000131	0.00054	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CCL3—multiple sclerosis	0.000129	0.000535	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CCR5—multiple sclerosis	0.000129	0.000535	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CCR5—multiple sclerosis	0.000129	0.000533	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CD86—multiple sclerosis	0.000128	0.000528	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CCR5—multiple sclerosis	0.000128	0.000528	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—TYK2—multiple sclerosis	0.000128	0.000527	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000128	0.000527	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—IL2RA—multiple sclerosis	0.000127	0.000525	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PTGER4—multiple sclerosis	0.000126	0.000522	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—IL2RA—multiple sclerosis	0.000126	0.00052	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PTGER4—multiple sclerosis	0.000126	0.00052	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CCL5—multiple sclerosis	0.000126	0.00052	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PTGER4—multiple sclerosis	0.000125	0.000515	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PGR—multiple sclerosis	0.000124	0.000514	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PGR—multiple sclerosis	0.000124	0.000512	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PGR—multiple sclerosis	0.000123	0.000507	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CD86—multiple sclerosis	0.000122	0.000506	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—IL2—multiple sclerosis	0.000122	0.000505	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CXCR3—multiple sclerosis	0.000122	0.000504	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CXCR3—multiple sclerosis	0.000122	0.000502	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CD28—multiple sclerosis	0.000121	0.000499	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CCL5—multiple sclerosis	0.00012	0.000498	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CD28—multiple sclerosis	0.00012	0.000498	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CXCR3—multiple sclerosis	0.00012	0.000497	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CD28—multiple sclerosis	0.000119	0.000493	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CCR2—multiple sclerosis	0.000119	0.00049	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CCR2—multiple sclerosis	0.000118	0.000489	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	0.000117	0.000484	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—IL2—multiple sclerosis	0.000117	0.000483	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—SPP1—multiple sclerosis	0.000117	0.000482	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CCR5—multiple sclerosis	0.000113	0.000468	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IL2RA—multiple sclerosis	0.000112	0.000462	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—SPP1—multiple sclerosis	0.000112	0.000461	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—POMC—multiple sclerosis	0.000111	0.00046	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—POMC—multiple sclerosis	0.000111	0.000459	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—IL2—multiple sclerosis	0.000111	0.000458	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	0.00011	0.000454	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CNR1—multiple sclerosis	0.000109	0.000452	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CNR1—multiple sclerosis	0.000109	0.000451	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CCR5—multiple sclerosis	0.000109	0.000449	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	0.000108	0.000447	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IL2RA—multiple sclerosis	0.000107	0.000442	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—IL2—multiple sclerosis	0.000106	0.000439	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—APOE—multiple sclerosis	0.000103	0.000426	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—POMC—multiple sclerosis	0.000101	0.000418	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—POMC—multiple sclerosis	0.000101	0.000417	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	9.98e-05	0.000412	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CCL2—multiple sclerosis	9.89e-05	0.000409	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—APOE—multiple sclerosis	9.88e-05	0.000408	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CCL2—multiple sclerosis	9.86e-05	0.000408	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CXCL10—multiple sclerosis	9.86e-05	0.000407	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CXCL10—multiple sclerosis	9.82e-05	0.000406	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	9.77e-05	0.000404	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	9.73e-05	0.000402	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CD80—multiple sclerosis	9.32e-05	0.000385	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—TYK2—multiple sclerosis	8.98e-05	0.000371	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—TYK2—multiple sclerosis	8.96e-05	0.00037	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CD80—multiple sclerosis	8.93e-05	0.000369	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	8.87e-05	0.000366	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—POMC—multiple sclerosis	8.86e-05	0.000366	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CCL2—multiple sclerosis	8.67e-05	0.000358	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CD86—multiple sclerosis	8.62e-05	0.000356	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CD86—multiple sclerosis	8.59e-05	0.000355	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CD86—multiple sclerosis	8.51e-05	0.000352	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—POMC—multiple sclerosis	8.48e-05	0.000351	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CCL5—multiple sclerosis	8.48e-05	0.000351	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—MAPK1—multiple sclerosis	8.48e-05	0.00035	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CCL5—multiple sclerosis	8.46e-05	0.000349	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	8.37e-05	0.000346	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CCL2—multiple sclerosis	8.3e-05	0.000343	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—APOE—multiple sclerosis	8.29e-05	0.000343	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—IL2—multiple sclerosis	8.23e-05	0.00034	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—IL2—multiple sclerosis	8.21e-05	0.000339	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	8.13e-05	0.000336	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—MAPK1—multiple sclerosis	8.12e-05	0.000336	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—TYK2—multiple sclerosis	7.87e-05	0.000325	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—SPP1—multiple sclerosis	7.86e-05	0.000325	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—SPP1—multiple sclerosis	7.83e-05	0.000324	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	7.76e-05	0.000321	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CCR5—multiple sclerosis	7.64e-05	0.000316	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CCR5—multiple sclerosis	7.62e-05	0.000315	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	7.55e-05	0.000312	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—TYK2—multiple sclerosis	7.54e-05	0.000311	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IL2RA—multiple sclerosis	7.53e-05	0.000311	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IL2RA—multiple sclerosis	7.51e-05	0.00031	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—IL2—multiple sclerosis	7.48e-05	0.000309	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—IL2—multiple sclerosis	7.45e-05	0.000308	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	7.44e-05	0.000307	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	7.38e-05	0.000305	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—POMC—multiple sclerosis	7.12e-05	0.000294	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—APOE—multiple sclerosis	6.95e-05	0.000287	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—APOE—multiple sclerosis	6.93e-05	0.000286	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—APOE—multiple sclerosis	6.86e-05	0.000284	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IL2—multiple sclerosis	6.55e-05	0.000271	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—IL6—multiple sclerosis	6.52e-05	0.000269	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—ALB—multiple sclerosis	6.49e-05	0.000268	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CD80—multiple sclerosis	6.29e-05	0.00026	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IL2—multiple sclerosis	6.27e-05	0.000259	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CD80—multiple sclerosis	6.27e-05	0.000259	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—IL6—multiple sclerosis	6.24e-05	0.000258	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CD80—multiple sclerosis	6.21e-05	0.000256	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MMP9—multiple sclerosis	6.2e-05	0.000256	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—POMC—multiple sclerosis	5.97e-05	0.000247	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—POMC—multiple sclerosis	5.95e-05	0.000246	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MMP9—multiple sclerosis	5.94e-05	0.000245	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—POMC—multiple sclerosis	5.9e-05	0.000244	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	5.84e-05	0.000242	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CCL2—multiple sclerosis	5.83e-05	0.000241	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	5.77e-05	0.000238	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	5.72e-05	0.000236	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—MAPK1—multiple sclerosis	5.7e-05	0.000236	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	5.65e-05	0.000233	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—STAT3—multiple sclerosis	5.51e-05	0.000228	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	5.31e-05	0.000219	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TYK2—multiple sclerosis	5.29e-05	0.000219	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—STAT3—multiple sclerosis	5.28e-05	0.000218	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	5.24e-05	0.000216	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MYC—multiple sclerosis	5.12e-05	0.000212	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—TGFB1—multiple sclerosis	5.11e-05	0.000211	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MAPK1—multiple sclerosis	5.01e-05	0.000207	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MYC—multiple sclerosis	4.9e-05	0.000203	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—TGFB1—multiple sclerosis	4.89e-05	0.000202	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MAPK1—multiple sclerosis	4.8e-05	0.000198	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IL2—multiple sclerosis	4.42e-05	0.000182	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IL2—multiple sclerosis	4.4e-05	0.000182	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	4.39e-05	0.000182	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—IL6—multiple sclerosis	4.38e-05	0.000181	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IL2—multiple sclerosis	4.36e-05	0.00018	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	4.34e-05	0.000179	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	4.18e-05	0.000173	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MMP9—multiple sclerosis	4.17e-05	0.000172	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	4.13e-05	0.00017	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IL6—multiple sclerosis	3.85e-05	0.000159	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	3.72e-05	0.000154	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—STAT3—multiple sclerosis	3.7e-05	0.000153	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IL6—multiple sclerosis	3.69e-05	0.000152	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	3.67e-05	0.000152	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MYC—multiple sclerosis	3.45e-05	0.000143	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	3.44e-05	0.000142	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MYC—multiple sclerosis	3.44e-05	0.000142	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TGFB1—multiple sclerosis	3.43e-05	0.000142	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MYC—multiple sclerosis	3.41e-05	0.000141	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	3.4e-05	0.000141	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	3.38e-05	0.00014	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MAPK1—multiple sclerosis	3.37e-05	0.000139	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	3.33e-05	0.000138	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IL6—multiple sclerosis	2.6e-05	0.000107	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IL6—multiple sclerosis	2.59e-05	0.000107	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IL6—multiple sclerosis	2.56e-05	0.000106	CbGpPWpGaD
